UPGRADE gathers together leading European and an American scientists in field of precision gene therapy. Together, this consortium has the unique expertise to create innovative tools to expand efficacy and safety of gene targeting technologies, convert viral-vectors to specifically target cell types and decreased immunogenicity of novel AMP.
A consortium with a proven track record of successful cooperation by partners: all partners contribute to multiple work packages, building a highly integrated consortium that will work together as an optimal structure.
List of Partners
 |
FONDAZIONE TELETHON | Italy |
 |
POMPEU FABRA UNIVERSITY | Spain |
 |
UNIVERSITY OF TRENTO | Italy |
 |
TECHNISCHE UNIVERSITAET DRESDEN | Germany |
 |
VRIJE UNIVERSITEIT BRUSSEL | Belgium |
 |
UNIVERSITY OF NANTES | France |
 |
LUDWIG-MAXIMILIANSUNIVERSITAET MUENCHEN | Germany |
 |
MASSACHUSETTS GENERAL HOSPITAL | United States |